Quiz 1 Flashcards
Diffuse scleroderma has a early and significant incidence of? (list 2 organ systems involved)
Renal and interstitial lung disease
Ab assoc w/ diffuse scleroderma
-what is the Ab against?
Anti-Scl 70 -> anti-DNA Topoisomerase I
Skin involvement w/ lmtd scleroderma
Hands, face, feet and forearms (Acral distribution)
Pulm HTN and renal disease incidence in lmtd scleroderma
Late incidence PHTN -> 10-15%
Renal disease RARELY occurs
Ab seen w/ lmtd scleroderma
At which stage of the cell cycle does it attack?
Anticentromere Ab (ACA)
metaphase
Define CREST
Calcinosis -> dystrophic calcification of subcutaneous tissue
Raynaud’s phenomenon
Esophageal dysmotility
Sclerodactyly -> tight skin
Telangiectasia -> punctate blood vessel dilations
Difference b/w raynaud’s phenomenon and disease with regards to finger involvement
Disease -> healthy people
-symmetric involvement of fingers; usually all
Phenomenon -> 2ndary to disease
-asymmetric involvement of fingers
PHTN etiology in systemic vs lmtd scleroderma
Systemic -> 2ndary to ILD
Lmtd -> vaso-occlusive
Imaging of intestines in scleroderma patients with GI involvement
Stacked coin pattern w/ pseudodiverticula (doesn’t go through the muscle)
Scleroderma renal crisis often confused with what? when is this confusion increased?
TTP/HUS -> both have microangiopathic hemolysis and thrombocytopenia
If patient w/ renal crisis and no HTN -> confusion inc
DO NOT GIVE STEROIDS IF SCLERODERMA
MCTD contains clinical features of which disorders?
SLE, Scleroderma, polymyositis
Occasionally Sjogren’s and RA
High titer of which Ab in MCTD?
Anti-U1RNP Abs = HALLMARK
antibodies against a U1 ribonucleoprotein complex
Early clinical manifestations of MCTD
generalized malaise
arthralgias
low-grade fever
List 4 signs/sxs suggestive of MCTD
- hands
- renal and CNS disease
- arthritis
- PHTN
Raynaud’s w/ swollen hands and puffy fingers
-more impressive than scleroderma
Absence of severe renal and CNS disease
More severe arthritis than expected in CT disease
Insidious onset PHTN -> not always related to interstitial lung disease
-very bad news
Jaccoud’s arthropathy
deforming non erosive arthropathy characterised by ulnar deviation of the second to 5th fingers with MCP subluxation.
IMPORTANT -> correctable!
-b/c problem with ligaments
Confirmatory dx for Sjogren’s
Labial salivary gland bx
Key histologic feature of Sjogren’s
Focal collection or collections of LYMPHOCYTES
foci -> 50+ lymphocytes/4mm^2
Positive test > 1 foci aggregate per 4mm^2
Abs seen w/ Sjogren’s
Anti-Ro and/or SS-B (anti-La)
Also RF
Define Sjogren’s. Which type of HSR?
Autoimmune destruction of exocrine glands
-lacrimal and salivary are top 2
TYPE IV HSR
Define fibromyalgia
- criteria for dx
- proposed cause
- factors involved in the etiology
- Chronic widespread pain and tenderness (>/= 3 months)
- Due to abnormal responsiveness or function of CNS
- Familial, environmental and genetic factors involved
Hallmark clinical features of fibromyalgia (list 8)
- chronic widespread pain
- sleep disturbance
- fatigue
- tenderness
- stiffness
- mood disturbances (anxiety, depression)
- Cognitive difficulties (dec concentration, forgetfulness, disorganization)
- Fxal impairment
Central pain disorders respond which type of pharmacologic tx?
neuroactive compounds
DESCENDING PATHWAY TARGETS
- serotonin
- NE
ASCENDING PATHWAY
- glutamate
- substance P
List 7 clinical characteristics of central pain disorders
- multifocal pain and diffuse tenderness
- higher current and lifetime hx of pain
- multiple other somatic sxs (fatigue, memory, sleep issues etc.)
- Sensitivity to multiple sensory stimuli (light, sound etc)
- more common in WOMEN
- strong familial/genetic underpinnings
- triggered or exacerbated by stressors
Mech of pregabalin (lyrica)
- ascending or descending pathway?
- MC side effect reported?
Binds to alpha-2-delta subunit of VG Ca++ channels or neurons -> reduces Ca++ influx at nerve terminals -> inhibited release of GLUTAMATE and SUBSTANCE P
Works on the ASCENDING PATHWAY
MC side effect -> Dizziness
Duloxetine (cymbalta) and milnacipran (savella) MoA
- ascending or descending pathway?
- MC side effect reported?
SNRIs -> inhibit serotonin and NE reuptake
- DESCENDING pathway
- Nausea and headache
Non-pharm tx approaches for management of FM (list 4)
- Exercise
- aerobic
- 30-60 min of low to moderate intensity >/= 2 to 3x per week - CBT
- PT
- Lifestyle and diet mods
Match the appropriate drug choice for FM with the following presentations:
- pain, fatigue, depressed mood
- pain, sleep disturbance, anxiety
- pain, fatigue, depressed mood -> use SNRI (duloxetine, milnacipran)
- pain, sleep disturbance, anxiety -> pregabalin (alpha-2-delta ligand)
5 components of metabolic syndrome
- high fasting glucose
- high TG
- low HDL
- high BP
- high waist circumference
Impaired fasting glucose / impaired glucose tolerance
IFG -> 100-125
IGT -> 140-199
Diabetes criteria based on fasting plasma glucose and OGTT
FPG >/= 126
OGTT (2 hr post glucose load) >/= 200
General HbA1c target range
Post and pre prandial glucose?
HbA1c < 7.0% (individualize to the patient)
Pre-prend< 130 mg/dL
Post-prandial PG <180 mg/dL
Biguanides (metformin)
- MoA
- side effects
MECH
- Activates AMP-kinase
- dec hepatic glucose production
SE
- Gastrointestinal
- Lactic acidosis -> rare but 50% mortality
- B-12 deficiency
- Contraindications -> renal failure
Sulfonylureas/meglitinides
- MoA
- side effects
MECH
-Closes KATP channels -> Insulin secretion
SE
- Hypoglycemia
- Weight gain
- Low durability
Meglitinides are NON-sulfonylurea secretagogues
Thiazolidinediones (pioglitazone)
- MoA
- side effects
MECH
Binds to PPAR-gamma nuclear transcription regulator -> inc insulin sensitivity in peripheral tissues
SE
- weight gain
- edema
- hepatotoxicity
- heart failure
- bone fractures
DPP-4 inhibitors
- linagliptin
- saxagliptin
- sitagliptin
inhibits breakdown of incretins (GLP-1 and GIP) -> DEC glucagon release and INC insulin release
SE
- only modest dec in A1c
- maybe pancreatitis
- urticaria
Alpha-glucosidase inhibitors
- Inhibits α- glucosidase
- Slows carbohydrate absorption -> dec postprandial hyperglycemia
Basically medically induced lactose intolerance
SE
-GI -> osmotic diarrhea, gas
Insulin independent glucose uptake
BRICK L
- Brain
- RBCs
- Intestine
- Cornea
- Kidney
- Liver
human health hazard =
(Inherent toxicity) x (exposure)
Exposure = (dose) x (time)
How do people get poisoned?
1) 1-5 years
2) 5 - 18
3) Adult
1-5 -> accidental
5-18 -> accidental but increasingly intentional
Adults
- intentional -> OD, suicide
- accidental -> occupational exposure or incorrect dosing (elderly)
Opioid Toxidrome
-antidote?
Classic triad -> opioid OD until proven otherwise
- coma
- resp depression
- miosis
Also
- hypoTN
- bradycardia
Antidote -> Naloxone
Cholinergic toxidrome (use mnemonic)
antidote
D - defecation/diarrhea U - urination M - miosis B - bradycardia B - bronchospasms/bronchorrhea E - emesis/excitation of skeletal muscles L - lacrimation S - sweating / salivation
Antidote -> atropine (competitive inhibitor) or pralidoxime (regenerates AChE if given early)
Sympathomimetic toxidrome
- think?
- some drugs
- treatment?
Think withdrawal (alcohol, benzos) along with the sympathomimetic drugs
HTN -> stroke, MI, aortic rupture Tachy -> arrhythmia Hyperpyrexia -> heat stroke Mydriasis Anxiety/delirium Diaphoresis
Drugs
- caffeine
- ephedrine
- cocaine
- ritalin (methylphenidate)
- amphetamines
Tx -> BENZOS: depress release of catecholamines from the CNS
Anticholinergic toxidromes
Think opposite of DUMBBeLSS
Hot as a hare Dry as a bone Red as a beet Blind as a bat Mad as a hatter
How can you distinguish b/w parasympatholytic and sympathomimetic syndromes?
DIAPHORESIS -> only with sympathomimetic syndrome!
Life threats to muscarinic and nicotinic systems
Muscarinic -> bradycardia, bronchorrhea, seizures
Nicotoinic -> resp failure